drugset
Drugs / Autologous Human Cord Blood derived Stem Cell
last change Dec 2016 re-read 3 minutes ago

Autologous Human Cord Blood derived Stem Cell

Cell therapy

Developed for
pediatric arterial ischemic stroke
Investigated by
Aryn Knight · Baylor College of Medicine · Cord Blood Registry, Inc. · M.D. Anderson Cancer Center - Houston · The Institute for Rehabilitaion and Research Foundation · The University of Texas Health Science Center, Houston

Trials 1

today NCT01700166 · Ph 1
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01700166 Sep 2012 → Aug 2013 pediatric arterial ischemic stroke Aryn Knight Withdrawn No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Autologous Human Cord Blood derived Stem Cell ClinicalTrials.gov intervention name — accepted as the source's own label NCT01700166 ↗
Modality Cell therapy “Autologous Human Umbilical Cord Blood derived Stem Cell injection” NCT01700166 ↗
Route Intravenous “One time intravenous (in the vein) injection with two year follow-up” NCT01700166 ↗